The improvement in hepatic function associated with these probiotics in GalN-sensitized and alcoholic liver disease models is usually attributive to their direct precautionary action against the impairment of intestinal barrier, thus alleviating the aggravation of these diseases [12, 15–18]. This evidence concerns the gene GAL and alcoholic liver diseases.